MedPage Today on MSN
In-Utero Repair of Severe Spina Bifida With Stem Cells Shows Promise
A first in-human, phase I trial examined feasibility as well as safety ...
February 9, 2011 — Repairing a myelomeningocele in utero, rather than after birth, reduces the risk for fetal or neonatal death and the need for shunting by age 1 and substantially improves neurologic ...
Management of Myelomeningocele Study (MOMS) investigators analyzed updated data on the effects of prenatal myelomeningocele closure on the need for placement of a cerebrospinal fluid (CSF) shunt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results